Novo Nordisk cuts forecasts after replica obesity drugs hit US take-up
‘Compounded’ drugs custom made by pharmacies appeared after US regulator declared shortages in 2022
What's Your Reaction?
Like
0
Dislike
0
Love
0
Funny
0
Angry
0
Sad
0
Wow
0
